{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:16:44Z","timestamp":1763018204800,"version":"3.44.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.leukres.2020.106405","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T11:05:13Z","timestamp":1592219113000},"page":"106405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Impact of tyrosine kinase inhibitors on the statural growth in children with acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"95","author":[{"given":"Fang-yuan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-dong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-xi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-ping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.leukres.2020.106405_bib0005","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1556\/650.2018.31059","article-title":"New and traditional directions in the biology and management of childhood acute lymphoblastic leukemia","volume":"159","author":"Egyed","year":"2018","journal-title":"Orv. Hetil."},{"issue":"3","key":"10.1016\/j.leukres.2020.106405_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3345\/kjp.2011.54.3.106","article-title":"Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood","volume":"54","author":"Koo","year":"2011","journal-title":"Korean J. Pediatr."},{"issue":"1 Suppl","key":"10.1016\/j.leukres.2020.106405_bib0015","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.bbmt.2010.09.003","article-title":"Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?","volume":"17","author":"Suttorp","year":"2011","journal-title":"Biol. Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.leukres.2020.106405_bib0020","first-page":"962","article-title":"Efficacy and pharmacokinetics of imatinib mesylate in a child with chronic myeloid leukemia","volume":"44","author":"Sugawara","year":"2003","journal-title":"Rinsho Ketsueki"},{"issue":"7","key":"10.1016\/j.leukres.2020.106405_bib0025","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/leu.2014.30","article-title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children\u2019s Oncology Group study AALL0031","volume":"28","author":"Schultz","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2020.106405_bib0030","first-page":"205","article-title":"Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics","volume":"3","author":"Carpiuc","year":"2010","journal-title":"Oncol. Ther."},{"issue":"3","key":"10.1016\/j.leukres.2020.106405_bib0035","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3324\/haematol.2012.067447","article-title":"Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty","volume":"98","author":"Giona","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.leukres.2020.106405_bib0040","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3349\/ymj.2016.57.2.532","article-title":"A case of dasatinib-induced nephrotic syndrome in a child with philadelphia chromosome positive acute lymphoblastic leukemia","volume":"57","author":"Lim","year":"2016","journal-title":"Yonsei Med. J."},{"issue":"5","key":"10.1016\/j.leukres.2020.106405_bib0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/08880018.2012.691946","article-title":"Chronic myeloid leukemia (CML) in children: classical and newer therapeutic approaches","volume":"29","author":"Ampatzidou","year":"2012","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2020.106405_bib0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12185-008-0251-8","article-title":"Growth deceleration in a girl treated with imatinib","volume":"89","author":"Kimoto","year":"2009","journal-title":"Int. J. Hematol."},{"issue":"18","key":"10.1016\/j.leukres.2020.106405_bib0055","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1016\/j.ejca.2014.10.007","article-title":"Growth deceleration in children treated with imatinib for chronic myeloid leukaemia","volume":"50","author":"Millot","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.leukres.2020.106405_bib0060","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/pbc.24121","article-title":"Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia","volume":"59","author":"Rastogi","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.leukres.2020.106405_bib0065","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/pbc.22945","article-title":"Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy","volume":"56","author":"Hobernicht","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"issue":"9","key":"10.1016\/j.leukres.2020.106405_bib0070","first-page":"641","article-title":"Recommendations for the diagnosis and treatment of acute lymphoblastic leukemia in children (fourth revision)","volume":"52","author":"Hematology Group of Chinese Medical Pediatrics Association","year":"2014","journal-title":"Zhonghuaerkezazhi"},{"issue":"4","key":"10.1016\/j.leukres.2020.106405_bib0075","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jpeds.2011.03.046","article-title":"Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia","volume":"159","author":"Shima","year":"2011","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.leukres.2020.106405_bib0080","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/pbc.24397","article-title":"Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH\/IGF-1 axis","volume":"60","author":"Narayanan","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.leukres.2020.106405_bib0085","first-page":"6","article-title":"Abstracts of the annual meeting of french society of pharmacology and therapeutics, and INSERM clinical research centers (CIC) meeting, 12-14 June 2018, Toulouse, France","volume":"32","year":"2018","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.leukres.2020.106405_bib0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/pbc.23389","article-title":"Imatinib has adverse effect on growth in children with chronic myeloid leukemia","volume":"59","author":"Bansal","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"7","key":"10.1016\/j.leukres.2020.106405_bib0095","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s41559-018-0567-6","article-title":"Childhood ecology influences salivary testosterone, pubertal age and stature of Bangladeshi UK migrant men","volume":"2","author":"Magid","year":"2018","journal-title":"Nat. Ecol. Evol."},{"issue":"6","key":"10.1016\/j.leukres.2020.106405_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131192","article-title":"Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats","volume":"10","author":"Tauer","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.leukres.2020.106405_bib0105","doi-asserted-by":"crossref","first-page":"R721","DOI":"10.12659\/MSM.883599","article-title":"Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment","volume":"18","author":"Jaeger","year":"2012","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.leukres.2020.106405_bib0110","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1200\/JCO.2017.75.9597","article-title":"Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial","volume":"36","author":"Gore","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"S1","key":"10.1016\/j.leukres.2020.106405_bib0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.HS9.0000559876.36369.09","volume":"3","author":"Patterson","year":"2019","journal-title":"HemaSphere"},{"issue":"Suppl 1","key":"10.1016\/j.leukres.2020.106405_bib0120","first-page":"235","article-title":"Growth hormone treatment and adverse events","volume":"14","author":"Nishi","year":"2017","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"1","key":"10.1016\/j.leukres.2020.106405_bib0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","article-title":"Long-term safety of recombinant human growth hormone in children","volume":"95","author":"Bell","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.leukres.2020.106405_bib0130","first-page":"1","article-title":"Acquired neuro-secretory defect in growth hormone secretion due to Imatinib mesylate and the efficacy of growth hormone therapy in children with chronic myeloid leukemia","author":"Walia","year":"2019","journal-title":"Pediatr. Hematol. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:00:45Z","timestamp":1758934845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212620301107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":26,"alternative-id":["S0145212620301107"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106405","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of tyrosine kinase inhibitors on the statural growth in children with acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106405"}}